Literature DB >> 30198299

Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.

Nathaniel D Bachtel1, Greta A Beckerle1, Talia M Mota1, Miguel de Mulder Rougvie1, Rui André Saraiva Raposo1, R Brad Jones1, Douglas F Nixon1, Richard Apps1.   

Abstract

Much has been learnt from the functions of host restriction factors during acute and chronic HIV-1 infection, but far less is known about their role in HIV-1-infected individuals in which viral load is stably suppressed with antiretroviral therapy (ART). In this study transcriptional expression of 42 host restriction factors was determined for memory CD4+ T cells sorted from 10 uninfected and 21 HIV-1-infected individuals, treated with suppressive ART and for which the viral reservoir was quantified. No significant associations were observed between restriction factor expression and HIV-1 reservoir size, quantified by measurement of HIV-1 Gag DNA using droplet digital polymerase chain reaction, and by measurement of replication-competent inducible virus using quantitative viral outgrowth assays. Expression of eight of the restriction factors differed significantly, and with a false discovery rate of <10%, between ART-suppressed and uninfected individuals. APOBEC3G, ISG15, LGALS3BP, RNASEL, and MX2 were upregulated in the ART-suppressed individuals, likely because of increased levels of immune activation observed in virally suppressed compared with uninfected individuals. In contrast CDKN1A, TRIM11, and BRD4 were expressed at lower levels in ART-suppressed than uninfected individuals. This suggests perturbation of the CD4+ memory T cell compartment, in which a viral reservoir persists in HIV-1-infected individuals with effective ART. Modulation of restriction factor expression, or overrepresentation of cell subsets that intrinsically express these restriction factors at lower levels could result in the distinct expression of restriction factors observed in treated infected individuals.

Entities:  

Keywords:  HIV; antiretroviral therapy; persistent infection; restriction factors; viral reservoirs

Mesh:

Substances:

Year:  2018        PMID: 30198299      PMCID: PMC6343196          DOI: 10.1089/AID.2018.0162

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.

Authors:  Szu-Han Huang; Yanqin Ren; Allison S Thomas; Dora Chan; Stefanie Mueller; Adam R Ward; Shabnum Patel; Catherine M Bollard; Conrad Russell Cruz; Sara Karandish; Ronald Truong; Amanda B Macedo; Alberto Bosque; Colin Kovacs; Erika Benko; Alicja Piechocka-Trocha; Hing Wong; Emily Jeng; Douglas F Nixon; Ya-Chi Ho; Robert F Siliciano; Bruce D Walker; R Brad Jones
Journal:  J Clin Invest       Date:  2018-01-22       Impact factor: 14.808

2.  A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers.

Authors:  Jin Leng; Hsin-Pin Ho; Maria J Buzon; Florencia Pereyra; Bruce D Walker; Xu G Yu; Emmanuel J Chang; Mathias Lichterfeld
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

3.  Select host restriction factors are associated with HIV persistence during antiretroviral therapy.

Authors:  Mohamed Abdel-Mohsen; Charlene Wang; Matthew C Strain; Steven M Lada; Xutao Deng; Leslie R Cockerham; Christopher D Pilcher; Frederick M Hecht; Teri Liegler; Douglas D Richman; Steven G Deeks; Satish K Pillai
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

Review 4.  Inflammation, Immune Activation, and Antiretroviral Therapy in HIV.

Authors:  Corrilynn O Hileman; Nicholas T Funderburg
Journal:  Curr HIV/AIDS Rep       Date:  2017-06       Impact factor: 5.071

5.  Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells.

Authors:  Rui André Saraiva Raposo; Mohamed Abdel-Mohsen; Miroslawa Bilska; David C Montefiori; Douglas F Nixon; Satish K Pillai
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

6.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

7.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

8.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

9.  Expression profile of host restriction factors in HIV-1 elite controllers.

Authors:  Mohamed Abdel-Mohsen; Rui André Saraiva Raposo; Xutao Deng; Manqing Li; Teri Liegler; Elizabeth Sinclair; Mohamed S Salama; Hussam El-Din A Ghanem; Rebecca Hoh; Joseph K Wong; Michael David; Douglas F Nixon; Steven G Deeks; Satish K Pillai
Journal:  Retrovirology       Date:  2013-10-16       Impact factor: 4.602

  9 in total
  3 in total

Review 1.  The BET family in immunity and disease.

Authors:  Nian Wang; Runliu Wu; Daolin Tang; Rui Kang
Journal:  Signal Transduct Target Ther       Date:  2021-01-19

Review 2.  Pharmacological Modulation of BET Family in Sepsis.

Authors:  Nian Wang; Runliu Wu; Paul B Comish; Rui Kang; Daolin Tang
Journal:  Front Pharmacol       Date:  2021-03-11       Impact factor: 5.810

3.  Downregulation of SERINC5 expression in buffy coats of HIV-1-infected patients with detectable or undetectable viral load.

Authors:  Elsie Guadalupe Hernández-López; Gracia Viviana González-Enríquez; Blanca Miriam Torres-Mendoza; Jhonathan Cárdenas-Bedoya; Martha Escoto-Delgadillo; Eduardo Vázquez-Valls; Alma Minerva Pérez-Ríos; David Alejandro Carbajal-Uribe; Ana Rosa Rincón-Sánchez
Journal:  Mol Biol Rep       Date:  2021-06-07       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.